| Metric | This Period | Prior-Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥308.5B | ¥313.2B | -1.5% |
| Operating Income / Operating Profit | ¥37.0B | ¥37.1B | -0.2% |
| Ordinary Income | ¥37.9B | ¥37.3B | +1.8% |
| Net Income / Net Profit | ¥27.9B | ¥25.6B | +8.9% |
| ROE | 6.4% | 6.0% | - |
For the six months ended Q2 FY2026, Revenue was ¥308.5B (¥-4.7B YoY, -1.5%), Operating Income was ¥37.0B (¥-0.1B YoY, -0.2%), Ordinary Income was ¥37.9B (¥+0.6B YoY, +1.8%), and Net Income was ¥27.9B (¥+2.3B YoY, +8.9%). Declines in sales of chemical industrial products depressed top-line performance, but gross margin improved to 28.0% (from 26.5% prior year, +1.5pt) enhancing profitability. Machinery manufacturing & sales maintained a high margin of 21.2%, supporting Operating Income. Ordinary Income rose slightly due to stable non-operating income contribution, and Net Income benefited from one-off Special Income of ¥3.5B (investment securities disposal gains ¥0.5B, property disposal gains ¥0.6B) and lower tax burden, resulting in an 8.9% increase year-on-year. Progress versus full-year plan (Revenue ¥629.0B, Operating Income ¥59.0B) stands at 49.0% for Revenue and 62.7% for Operating Income, indicating early profit progress; first-half Operating Margin of 12.0% exceeds the full-year assumed level (approx. 9.4%).
[Revenue] Revenue was ¥308.5B (-1.5% YoY), a slight decline. Core chemical industrial products sales fell to ¥220.1B (-2.1% YoY), accounting for 71.3% of sales; soft demand in this segment dragged on consolidated Revenue. Machinery manufacturing & sales held steady at ¥88.4B (±0.0% YoY), 28.7% of sales, providing support. Cost of goods sold decreased to ¥222.0B (from ¥228.5B prior year, -2.8%), yielding Gross Profit of ¥86.5B (+2.4% YoY) and a materially improved Gross Margin of 28.0% (from 26.5% prior year, +1.5pt). Improvements are attributed to progress in passing through prices and a favorable product mix.
[Profitability] Selling, General and Administrative Expenses (SG&A) increased to ¥49.5B (from ¥47.5B prior year, +4.0%), raising SG&A ratio to 16.0% (from 15.2% prior year, +0.8pt). With declining Revenue and higher fixed costs, operating leverage reversed, restraining Operating Income growth. Operating Income was ¥37.0B (-0.2% YoY), effectively flat, and Operating Margin was 12.0% (from 11.9% prior year, +0.1pt). Non-operating income totaled ¥1.0B (dividends received ¥0.3B, interest received ¥0.04B, etc.), and non-operating expenses ¥0.1B (commissions paid ¥0.1B, foreign exchange losses ¥0.16B, etc.), resulting in Ordinary Income of ¥37.9B (+1.8% YoY). Special Income of ¥3.5B (investment securities disposal gains ¥0.5B, property disposal gains ¥0.6B, etc.) and Special Losses ¥0.1B (asset retirement losses ¥0.1B) were recorded, producing Profit Before Tax of ¥41.4B (+9.1% YoY). After deducting Income Taxes of ¥13.4B (effective tax rate 32.5%), Net Income was ¥27.9B (+8.9% YoY), and Net Margin improved to 9.1% (from 8.2% prior year, +0.9pt). In conclusion, the company achieved lower Revenue but higher profit due to Gross Margin improvement and the contribution of Special Income.
Chemical Industrial Products Sales posted Revenue of ¥220.1B (-2.1% YoY), Operating Income of ¥18.3B (+0.2% YoY), and Operating Margin of 8.3% (from 8.1% prior year, +0.2pt). Despite declining sales, slight profit growth likely reflects margin improvements. Machinery Manufacturing & Sales recorded Revenue of ¥88.4B (±0.0% YoY), Operating Income ¥18.7B (-0.7% YoY), and Operating Margin 21.2% (from 21.4% prior year, -0.2pt), maintaining a high margin and contributing 50.5% of consolidated Operating Income as the largest contributing segment. There is approximately a 13pt margin spread between segments; the high-margin machinery segment drives consolidated margins, while chemical is volume-dependent due to its larger scale.
[Profitability] ROE is 6.4% (Net Margin 9.1% × Total Asset Turnover 0.54 × Financial Leverage 1.30), placing it near the lower bound of its historically favorable range. Operating Margin of 12.0% improved slightly from 11.9% prior year (+0.1pt), and Gross Margin of 28.0% increased materially from 26.5% (+1.5pt). Conversely, SG&A ratio rose to 16.0% (from 15.2%, +0.8pt), indicating cost pressures that suppressed operating leverage. Net Margin improved to 9.1% (from 8.2%, +0.9pt), partly due to Special Income. [Cash Quality] Operating Cash Flow (OCF) was ¥10.3B versus Net Income of ¥27.9B, a low conversion ratio of 0.37x, indicating weak cash realization of profits. OCF subtotal (pre-working capital changes) was ¥19.4B; working capital deterioration was driven by Accounts Receivable increase -¥14.8B, Accounts Payable decrease -¥3.9B, and bonus reserve reversal -¥8.3B (estimated). Inventories decreased by ¥7.5B partially offsetting this, but overall cash conversion remains a challenge. OCF/EBITDA is 0.27x, a low level, while accrual ratio is 3.1% (healthy); however cash generation is lagging. [Investment Efficiency] Total Asset Turnover was 0.54x (down from 0.56x prior year), due to slight Revenue decline and working capital buildup. DSO is 168 days, DIO 161 days, and CCC 246 days, all elongated, indicating substantial room to improve working capital efficiency. CapEx was ¥4.2B versus Depreciation ¥1.6B, yielding net investment of +¥2.6B, indicating an active investment stance. Intangible assets grew from ¥0.8B to ¥1.7B (+130%), reflecting increased investment in software, etc. [Balance Sheet Strength] Equity Ratio is 76.9% (from 75.8% prior year, +1.1pt), Current Ratio 349%, Quick Ratio 296%, indicating extremely strong liquidity. Debt-to-equity is 0.30x, effectively debt-free; short-term liabilities of ¥118.5B are well covered by Cash ¥121.8B and Accounts Receivable ¥141.6B. Deferred tax liabilities increased from ¥8.6B to ¥11.8B (+37%), signaling rising future tax burdens due to expanding unrealized gains — a point to monitor.
OCF was ¥10.3B (substantially improved from -¥11.8B prior year), but remains low relative to Net Income (conversion ratio 0.37x), highlighting cash realization issues. OCF subtotal (pre-working capital) was ¥19.4B; principal working capital movements were Accounts Receivable increase -¥14.8B (DSO 168 days, prolonged), Inventory decrease +¥7.5B (DIO 161 days, high though improved from prior year), Accounts Payable decrease -¥3.9B (impacted by -48.8% reduction in electronic recording payables), and bonus reserve reversal -¥8.3B (down from ¥24.5B prior year to ¥16.2B). Income taxes paid were -¥9.4B, and interest and dividends received +¥0.3B, resulting in total OCF of ¥10.3B. Investing Cash Flow was -¥4.6B, mainly CapEx -¥4.2B (construction in progress increased from ¥0.8B to ¥4.7B) and intangible asset investment -¥1.1B; property disposals +¥0.6B partially offset this, yielding Free Cash Flow of ¥5.7B. Financing Cash Flow was -¥19.8B, driven by dividend payments -¥10.8B and share buybacks -¥9.0B. Total shareholder returns of approx. ¥19.8B exceeded Free Cash Flow ¥5.7B, implying cash reserves were drawn down to fund returns. Cash decreased from ¥133.7B to ¥121.8B (-¥11.9B); improving working capital efficiency and cash generation will be key going forward.
Operating Income of ¥37.0B, as recurring earnings, remained resilient due to Gross Margin improvement, but Net Income of ¥27.9B includes Special Income ¥3.5B (approx. 12.5% of Net Income), reflecting one-off uplift. Special Income breakdown: investment securities disposal gains ¥0.5B, property disposal gains ¥0.6B; reproducibility is low. Non-operating income ¥1.0B (0.3% of Revenue) comprises stable items such as dividends received ¥0.3B and interest received ¥0.04B; foreign exchange loss ¥0.16B had minor impact. The gap between Ordinary Income ¥37.9B and Net Income ¥27.9B is explained by Income Taxes ¥13.4B (effective tax rate 32.5%) and net special items. Accrual ratio at 3.1% is within a healthy range, but OCF ¥10.3B is far below Net Income ¥27.9B (OCF/Net Income 0.37x), raising concerns about delayed cash realization. Comprehensive Income ¥30.6B versus Net Income ¥27.9B difference of ¥2.7B comprises valuation differences on securities +¥2.7B, foreign currency translation adjustments +¥0.7B, deferred hedge gains/losses -¥0.2B, and retirement benefit adjustments -¥0.6B; unrealized gains on securities are the primary driver.
Full-year plan unchanged: Revenue ¥629.0B (+6.0% YoY), Operating Income ¥59.0B (+10.2% YoY), Ordinary Income ¥60.0B (+11.1% YoY), Net Income ¥44.0B, EPS ¥149.54, Annual Dividend ¥40 (interim dividend equivalent after stock split ¥24.33, representing an effective increase). First-half progress rates are Revenue 49.0%, Operating Income 62.7%, Ordinary Income 63.2%, Net Income 63.4%, indicating profit progress exceeding the standard 50% by over 10% in profit metrics. First-half Operating Margin of 12.0% versus full-year plan implied Operating Margin of approx. 9.4% (=59.0/629.0), about 2.6pt lower, suggesting second-half assumptions likely include seasonality, higher costs, and inventory correction leading to margin compression. First-half Special Income ¥3.5B is one-off and not expected to recur for the full year; monitoring core second-half profit-generating ability is important. Contract liabilities ¥10.7B (from ¥10.3B prior year, +3.2% slight increase) support order progress but no material order surge is evident; second-half Revenue growth depends on demand trends and normalization of working capital.
Interim dividend was ¥36 per share (pre-split basis), total dividend payout approx. ¥10.6B (estimate), with payout ratio 38.0%, a sustainable level. Full-year dividend forecast is ¥40 (post-split equivalent annual ¥60.33, YoY +¥15.67 increase), representing a large effective increase on a post-split basis. However, Free Cash Flow ¥5.7B is insufficient to cover dividends approx. ¥10.8B (FCF coverage 0.53x). Total shareholder returns including share buybacks of ¥9.0B total approx. ¥19.8B, and total return ratio versus Net Income ¥27.9B is approx. 71%, high but within tolerable range. The company executed shareholder returns by drawing down cash in the first half; recovery of OCF and normalization of working capital in the second half are key to sustaining dividends. Given Cash ¥121.8B and OCF subtotal ¥19.4B, short-term dividend capacity is sufficient, but medium-to-long-term improvement in cash generation is essential.
Cash Flow Quality Risk: OCF ¥10.3B is 0.37x of Net Income ¥27.9B, and OCF/EBITDA is 0.27x — low levels indicating weak cash realization. DSO 168 days, DIO 161 days, CCC 246 days show extended working capital cycles; Accounts Receivable increase -¥14.8B, Accounts Payable decrease -¥3.9B, and bonus reserve reversal -¥8.3B were primary drivers of working capital deterioration. Without strengthened collections and inventory optimization in the second half, additional working capital needs may arise, constraining shareholder returns and investment funding.
Segment Concentration Risk: Chemical Industrial Products Sales account for 71.3% of Revenue, and its -2.1% sales decline pulled down consolidated Revenue. With Operating Margin 8.3% versus Machinery 21.2% (approx. 13pt difference), chemical is volume-dependent. Machinery is high-margin but remains 28.7% of sales; demand swings or raw material price volatility in chemical directly affect consolidated results. Delays in passing through costs or demand contractions could reverse Gross Margin improvements and sharply reduce Operating Income.
Mismatch Risk between Financial Returns and Cash Outflows: Free Cash Flow ¥5.7B versus dividends + share buybacks ~¥19.8B led to a cash drawdown of -¥11.9B. Deferred tax liabilities increased +¥3.2B (due to unrealized gains, etc.), indicating rising future tax burden, and construction in progress accumulation +¥3.9B suggests future ramp-up and higher depreciation. If working capital stagnation continues, pursuing aggressive shareholder returns alongside investments could erode liquidity and constrain financial flexibility.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 12.0% | 8.8% (3.0%–11.0%) | +3.2pt |
| Net Margin | 9.1% | 5.4% (1.1%–8.2%) | +3.6pt |
Profitability substantially exceeds the industry median and occupies a top position. The machinery segment’s high margin of 21.2% boosts consolidated margins, and Gross Margin improvement to 28.0% contributed.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | -1.5% | 11.7% (-5.4%–28.3%) | -13.2pt |
Revenue growth lags the industry median by 13.2pt, reflecting the decline in chemical industrial products sales. The company ranks lower on growth within the industry.
※Source: Company compilation
Margin improvement and early progress: Gross Margin 28.0% improved materially by +1.5pt year-on-year, and Operating Margin 12.0% exceeds the industry median of 8.8% by +3.2pt. With 62.7% progress toward full-year Operating Income, sustained first-half margin gains could lead to upside to the full-year plan. Pay attention to segment-level margin trends and SG&A trajectory in the second half, given the machinery segment’s high Operating Margin of 21.2% that drives consolidated margins.
Improvement in Cash Flow Quality is critical: OCF ¥10.3B is 0.37x of Net Income ¥27.9B, and DSO 168 days / DIO 161 days / CCC 246 days indicate prolonged working capital cycles. If collections and inventory optimization accelerate in the second half, OCF could improve substantially and Free Cash Flow could turn positive on a sustained basis. The company used cash reserves in the first half to deliver total returns of approx. ¥19.8B; second-half cash generation is directly linked to the sustainability of shareholder returns and financial flexibility. Progress in normalizing working capital is the single most important point to watch in upcoming results.
This report is an earnings analysis document automatically generated by AI analyzing XBRL earnings release data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the firm based on public disclosure data. Investment decisions are your own responsibility; please consult a professional advisor as necessary.